Research Topics
Species | Mony J de LeonSummaryAffiliation: New York University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's diseaseLidia Glodzik-Sobanska
New York University School of Medicine, New York, NY 10016, United States
Neurobiol Aging 30:672-81. 2009..The data also suggest that T-tau changes are more age dependent than Abeta changes. The evidence that P-tau231 and IP are the earliest markers for the neuronal damage related to AD awaits longitudinal study...
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET)M J de Leon
Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
Proc Natl Acad Sci U S A 98:10966-71. 2001..Further study is required to estimate individual risks and to determine the physiologic basis for METglu changes detected while cognition is normal...
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's diseaseM J de Leon
Center for Brain Health, NYU School of Medicine, Department of Psychiatry, 560 First Ave, New York 10016, USA
Ann N Y Acad Sci 1097:114-45. 2007..Moreover, selected combinations of imaging and CSF biomarkers measures are of importance in monitoring the course of AD and thus relevant to evaluating clinical trials...
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon
Department of Psychiatry, New York University School of Medicine New York, Center for Brain Health of the Silberstein Institute, NY 10016, USA
Neurobiol Aging 27:394-401. 2006..These results demonstrate that CSF biomarkers for AD contribute to the characterization of MCI...
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairmentM J de Leon
Centre for Brain Health, Department of Psychiatry, New York University School of Medicine, NY 10016, USA
Neurosci Lett 333:183-6. 2002..Longitudinally, only after adjusting for the ventricular volume and only for Ptau231, were increases seen in MCI. Further studies are warranted on mechanisms of tau clearance and on using imaging to interpret CSF studies...
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairmentMiroslaw Brys
New York University School of Medicine, NY, USA
Neurobiol Aging 30:682-90. 2009..To longitudinally evaluate five cerebrospinal fluid (CSF) biomarkers in the transition from mild cognitive impairment (MCI) to Alzheimer's disease (AD)...
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal eldersLidia Glodzik
Department of Psychiatry, New York University School of Medicine, Center of Excellence on Aging, Center for Brain Health, 145 East 32nd Street, 5th Floor, New York, NY 10016, USA
Neurobiol Aging 32:2131-41. 2011....
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's diseaseMiroslaw Brys
New York University School of Medicine, Center for Brain Health, NY 10016, USA
J Alzheimers Dis 16:351-62. 2009..05). These results provide support for including multiple modalities of biomarkers in the identification of memory clinic patients at increased risk for dementia...
Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathologyLidia Glodzik
Center for Brain Health, Department of Psychiatry, New York University School of Medicine, 145 East 32nd Street, 5th Floor, New York, NY10016, USA
J Alzheimers Dis 18:509-13. 2009..No treatment effects were seen among impaired individuals, suggesting that longer treatment time may be necessary to achieve biomarker effect in this group...
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parentsLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Neurobiol Aging 34:22-34. 2013..NH and ≥ 71% for MH vs. PH, with relative risk = 1.9-5.1 (p values < 0.005). NL individuals with AD-affected mothers show co-occurring Aβ increases and hypometabolism in AD-vulnerable regions, suggesting an increased risk for AD...
Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaintsLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
Biol Psychiatry 63:609-18. 2008....
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer'sLisa Mosconi
Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
Biol Psychiatry 68:913-21. 2010..With a panel of cerebrospinal fluid (CSF) markers, this study examined whether NL MH showed evidence for AD pathology compared with PH and NH...
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's diseaseLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Eur J Nucl Med Mol Imaging 36:811-22. 2009....
Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapniaLidia Glodzik
Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
J Cereb Blood Flow Metab 31:671-9. 2011..6, P=0.05). An elevated risk for vascular pathology is associated with a reduced response to hypercapnia in both hippocampal and cortical tissue. The VR(h) is more sensitive to vascular burden than either resting CBF or brain volume...
Hippocampal hypometabolism predicts cognitive decline from normal agingLisa Mosconi
New York University School of Medicine, New York, NY 10016, USA
Neurobiol Aging 29:676-92. 2008..This longitudinal study used FDG-PET imaging to predict and monitor cognitive decline from normal aging...
Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's diseaseLisa Mosconi
New York University School of Medicine, New York, NY 10016, USA
Neurobiol Aging 33:624.e1-9. 2012..There were no associations between paternal age and metabolism in any group. Evidence for a maternally inherited, maternal age-related mechanism provides further insight on risk factors and genetic transmission in late-onset AD...
Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive declineSusan De Santi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Neuropsychology 22:469-84. 2008..These findings indicate that Robust norms improve identification of healthy individuals who will decline and may be useful for selecting at-risk participants for research studies and early interventions...
Early detection of Alzheimer's disease using neuroimagingLisa Mosconi
Center for Brain Health MHL 400, New York University School of Medicine, 560 1st Avenue, New York, NY 10016, USA
Exp Gerontol 42:129-38. 2007..Overall, these studies show that the use of imaging for the early detection of AD is successful even in the earlier stages of disease when clinical symptoms are not fully expressed and the regional brain damage may be limited...
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer'sLisa Mosconi
New York University School of Medicine, New York, NY 10016, USA
Proc Natl Acad Sci U S A 107:5949-54. 2010..Present findings may motivate further research on familial transmission and parent-of-origin effects in LOAD...
Structural brain changes in normal individuals with a maternal history of Alzheimer'sValentina Berti
Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
Neurobiol Aging 32:2325.e17-26. 2011..Our findings support the use of regional brain atrophy as a preclinical biomarker for LOAD among at-risk individuals...
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's diseaseYi Li
New York University School of Medicine, New York, NY 10016, USA
Eur J Nucl Med Mol Imaging 35:2169-81. 2008....
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's diseaseDavangere P Devanand
Division of Geriatric Psychiatry, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
Biol Psychiatry 64:871-9. 2008..The utility of combining early markers to predict conversion from mild cognitive impairment (MCI) to Alzheimer's Disease (AD) remains uncertain...
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementiasLisa Mosconi
Center for Brain Health, New York University School of Medicine, New York, New York 10016, USA
J Nucl Med 49:390-8. 2008....
The role of quantitative structural imaging in the early diagnosis of Alzheimer's diseaseLidia Glodzik-Sobanska
Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
Neuroimaging Clin N Am 15:803-26, x. 2005..The last section describes problems encountered in the differential diagnosis...
An entorhinal cortex sulcal pattern is associated with Alzheimer's diseaseJiong Zhan
Department of Psychiatry, New York University School of Medicine, New York 10016, USA
Hum Brain Mapp 30:874-82. 2009..We classified the lateral EC sulcal boundary as either a rhinal or collateral pattern and tested the hypotheses that the rhinal pattern was (1) more common in AD and (2) associated with a smaller EC size...
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's diseaseLisa Mosconi
New York University School of Medicine, New York, New York 10016, USA
J Nucl Med 48:1129-34. 2007..We tested whether an (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals ("normals," or NLs) would improve diagnosis of AD and mild cognitive impairment (MCI)...
TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjectsAngela R Kamer
New York University, College of Dentistry, Department of Periodontology and Implant Dentistry, New York, NY 10010, USA
J Neuroimmunol 216:92-7. 2009..This study shows that TNF-alpha and elevated numbers of antibodies against periodontal bacteria associate with AD and contribute to the AD diagnosis...
Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's diseaseLisa Mosconi
Center for Brain Health, MHL 400, Department of Psychiatry, New York University School of Medicine, 560 First Avenue, New York, NY 10016, USA
Eur J Nucl Med Mol Imaging 34:1467-79. 2007....
Alzheimer's disease markers, hypertension, and gray matter damage in normal elderlyLidia Glodzik
Center of Excellence on Aging, Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Neurobiol Aging 33:1215-27. 2012..In this presymptomatic stage when no cognitive impairment is present, AD biomarkers and HTN have additive effects on gray matter damage...
Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairmentRichard P Kline
Department of Anesthesiology, New York University Langone Medical Center, New York, New York 10016, USA
Anesthesiology 116:603-12. 2012..Using magnetic resonance imaging data from the Alzheimer's Disease Neuroimaging Initiative, we tested the hypothesis that surgery would impact brain parameters associated with progression of dementia...
Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolismLisa Mosconi
Department of Psychiatry, New York University School of Medicine, 560 First Avenue, New York, NY 10016, USA
Proc Natl Acad Sci U S A 104:19067-72. 2007..No CMRglc differences were found between FHp and FH(-) subjects. This study shows a relationship between reduced CMRglc in AD-vulnerable brain regions and a maternal family history of AD in cognitively normal individuals...
Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PETLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Eur J Nucl Med Mol Imaging 33:210-21. 2006..We suggest this method be further evaluated for its potential in the early diagnosis of AD...
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imagingLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
J Alzheimers Dis 20:843-54. 2010..We then briefly review brain Abeta PET imaging studies in AD and discuss the potential of combining symptoms-sensitive FDG-PET measures with pathology-specific Abeta-PET to improve the early detection of AD...
Inflammation and Alzheimer's disease: possible role of periodontal diseasesAngela R Kamer
Department of Periodontology and Implant Dentistry, College of Dentistry, New York University, New York, NY, USA
Alzheimers Dement 4:242-50. 2008..Because chronic periodontitis is a treatable infection, it might be a readily modifiable risk factor for AD...
Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy studyLidia Glodzik
Center for Brain Health, Department of Psychiatry, New York University New York, NY 10016, USA
Prog Neuropsychopharmacol Biol Psychiatry 32:1005-12. 2008..Treatment with memantine decreased Glu/Cr (creatine) ratio in the left hippocampal region. Memantine reduced hippocampal glutamate levels, which may be consistent with its anti-excitotoxic property...
Magnetic resonance and PET studies in the early diagnosis of Alzheimer's diseaseLisa Mosconi
Department of Psychiatry, New York University School of Medicine, Center for Brain Health, 560 First Avenue, NY 10016, USA
Expert Rev Neurother 4:831-49. 2004..It is concluded that there is considerable promise for an early and specific diagnosis for Alzheimer's disease by combining information from imaging and biomarker modalities...
Hippocampal blood flow in normal aging measured with arterial spin labeling at 3THenry Rusinek
Department of Radiology, New York University School of Medicine, New York, New York, USA
Magn Reson Med 65:128-37. 2011..6 mL/(100 g min) or 5.4%. The 3T true fast imaging in steady precession arterial spin labeling method offers a HBF measurement strategy that combines good spatial resolution, sensitivity, and minimal image distortions...
Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findingsKevin G King
Department of Radiology, Center for Brain Health, New York University School of Medicine, 550 First Ave, New York, NY 10016, USA
Radiology 249:242-50. 2008..To quantify proton magnetic resonance (MR) spectroscopy-detectable metabolite concentrations along anteroposterior axis of hippocampus in healthy young and elderly subjects...
Subjective memory complaints: presence, severity and future outcome in normal older subjectsLidia Glodzik-Sobanska
Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
Dement Geriatr Cogn Disord 24:177-84. 2007..Subjective memory complaint (SMC) in normal individuals may predict future cognitive decline. The goal of this study was to examine whether the probability of decline increases with growing intensity of complaint...
Mild cognitive impairment (MCI): a historical perspectiveBarry Reisberg
Aging and Dementia Research Center, New York University School of Medicine, New York 10016, USA
Int Psychogeriatr 20:18-31. 2008..Nevertheless, longitudinal and other studies indicate essential compatibility between GDS stage 3 MCI and Petersen's MCI duration and outcomes...
Does mild cognitive impairment increase the risk of developing postoperative cognitive dysfunction?Alex Bekker
Department of Anesthesiology, New York University Medical Center, New York, NY, USA
Am J Surg 199:782-8. 2010..We sought to determine whether patients with mild cognitive impairment (MCI) would have an accelerated progression of dementia postoperatively when compared with the patients without MCI...
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's diseaseLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, New York, USA
J Nucl Med 47:1778-86. 2006....
The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's diseaseBarry Reisberg
Silberstein Aging and Dementia Research Center, New York University School of Medicine, New York, NY, USA
Alzheimers Dement 4:S98-S108. 2008..Subjective cognitive impairment (SCI) has been a common, but poorly understood condition, frequently occurring in older persons...
Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's diseaseLisa Mosconi
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Ann N Y Acad Sci 1147:180-95. 2008..The present paper reviews findings that implicate hypometabolism and oxidative stress as crucial players in the initiation and progression of synaptic pathology in AD...
Absence of hippocampal volume differences in survivors of the Nazi Holocaust with and without posttraumatic stress disorderJulia A Golier
Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY, USA
Psychiatry Res 139:53-64. 2005..Larger temporal lobe volumes may be associated with early traumatization and survival or may reflect some other characteristic of Holocaust survivors...
Salivary cortisol day profiles in elderly with mild cognitive impairmentOliver T Wolf
Center for Brain Health, Neuroimaging Laboratory, New York University School of Medicine, 560 First Avenue, NY, New York 10016, USA
Psychoneuroendocrinology 27:777-89. 2002..Whether cortisol levels, in conjunction with other factors, such as hippocampal volume, will lead to improved prediction of future decline to AD in participants with MCI remains to be established in longitudinal studies...
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal agingHenry Rusinek
Department of Radiology, New York University School of Medicine, Bellevue C and D Bldg, Room D120, 550 First Ave, New York, NY 10016, USA
Radiology 229:691-6. 2003..To determine if medial temporal lobe (MTL) atrophy rate, assessed by using an automated procedure over the initial time interval of a 6-year, three-time-point longitudinal study, is predictive of future memory decline...
Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderlyAntonio Convit
Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Proc Natl Acad Sci U S A 100:2019-22. 2003..This observation may bring to light a mechanism for aging brain injury that may have substantial medical impact, given the large number of elderly individuals with impaired glucose metabolism...
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF StudiesRachel Mistur
Department of Psychiatry, New York University School of Medicine, New York, NY, USA
J Clin Neurol 5:153-66. 2009..Finally, we will discuss the potential to combine different PET tracers and CSF markers of pathology to improve the early detection of AD...
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic miceEinar M Sigurdsson
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
Neurobiol Aging 29:836-47. 2008..3) Smaller, earlier plaques require contrast ligand for MRI visualization. Our ligand when combined with VBA may be useful for following therapeutic approaches targeting amyloid in transgenic mouse models...
Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesisAngela R Kamer
Department of Periodontics and Implant Dentistry and Basic Sciences, NYU College of Dentistry, New York, NY 10010, USA
J Alzheimers Dis 13:437-49. 2008..Since periodontitis is a treatable condition, it may be a readily modifiable risk factor for AD...
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's diseaseAllison B Reiss
Department of Medicine, New York University School of Medicine, New Bellevue 16N1, 550 First Avenue, New York, NY 10016, USA
Neurobiol Aging 25:977-89. 2004..The reduction in stroke and AD risk in patients treated with cholesterol-lowering statins is also discussed...
Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumesOliver T Wolf
Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
Neuroendocrinology 75:241-9. 2002..It remains possible that age-associated changes in fast feedback may be related to changes to other brain sites, such as hypothalamus or pituitary...
Seeing what Alzheimer sawMony J de Leon
Nat Med 13:129-31. 2007
Alzheimer's diseaseKaj Blennow
Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgren s University Hospital, Molndal, Sweden
Lancet 368:387-403. 2006..This seminar reviews the key aspects of the disease, including epidemiology, genetics, pathogenesis, diagnosis, and treatment, as well as recent developments and controversies...
Hippocampal atrophy disrupts transfer generalization in nondemented elderlyCatherine E Myers
Department of Psychology, Rutgers University, Newark, New Jersey 07102, USA
J Geriatr Psychiatry Neurol 15:82-90. 2002..These preliminary results suggest that even very mild degrees of hippocampal atrophy may be associated with subtle behavioral impairments...
Biomarkers for the early diagnosis of Alzheimer's diseaseMony J de Leon
Lancet Neurol 5:198-9. 2006
Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's diseaseRichard A Frank
Pharmacia Corporation, Mailstop 134, Peapack, NJ 07977, USA
Neurobiol Aging 24:521-36. 2003
Subjective memory complaints in aging are associated with elevated cortisol levelsOliver T Wolf
Institute for Experimental Psychology, University of Duesseldorf, Germany
Neurobiol Aging 26:1357-63. 2005..Differences in personality traits or in stress susceptibility might underlie the present findings. Future studies of memory complaints should take a comprehensive approach including relevant endocrine parameters...
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's diseaseJoseph A Helpern
Nathan S Kline Institute, Orangeburg, New York 10962, USA
Magn Reson Med 51:794-8. 2004..No differences in T(1) values or proton density were detected between any groups of mice. These results indicate that T(2) may be a sensitive marker of abnormalities in this transgenic mouse model of AD...
Changes in brain functional homogeneity in subjects with Alzheimer's diseaseNora D Volkow
Medical Department, Bldg 490, Brookhaven National Laboratory, P O Box 5000, Upton, NY 11973 5000, USA
Psychiatry Res 114:39-50. 2002..The enhanced CV in precuneus, despite its marked reductions in metabolism, suggests that increases in regional homogeneity in parietal and temporal cortices are not a mere reflection of the decrement in metabolism...
Research Grants
- PREDICTORS OF COGNITIVE DECLINE IN NORMAL AGINGMony de Leon; Fiscal Year: 2007..There are ample numbers of volunteer subjects and patients available. There is adequate statistical power for testing the hypotheses. ..
- CLINICAL CORRELATES OF LONGITUDINAL PET CHANGES IN ADMony de Leon; Fiscal Year: 2006..We have strong preliminary evidence in support of our hypotheses and all the facilities are in place. ..
- Imaging and the Aging BrainMony de Leon; Fiscal Year: 2006..In vivo imaging of molecules,2. Cells and networks throughout the lifespan;3. Imaging and physiology of aging; 4. Translational applications; 5. and Technologies at the forefront of imaging. ..
- Biomarkers in Early Alzheimer's DiseaseMony de Leon; Fiscal Year: 2007..Ample numbers of subjects are available, and we already completed the proposed three evaluations on 8 eligible NL subjects. There is adequate statistical power for testing the hypotheses. ..
- CLINICAL CORRELATES OF LONGITUDINAL PET CHANGES IN ADMony de Leon; Fiscal Year: 2009..This project will test the hypothesis that validated biological markers for neurofibrillary tangle and amyloid plaque pathology contribute to FDG-PET in predicting future cognitive decline in cognitively normal subjects. ..
- CLINICAL CORRELATES OF LONGITUDINAL PET CHANGES IN ADMony J de Leon; Fiscal Year: 2010..This project will test the hypothesis that validated biological markers for neurofibrillary tangle and amyloid plaque pathology contribute to FDG-PET in predicting future cognitive decline in cognitively normal subjects. ..
- PREDICTORS OF COGNITIVE DECLINE IN NORMAL AGINGMony de Leon; Fiscal Year: 2009..There are ample numbers of volunteer subjects and patients available. There is adequate statistical power for testing the hypotheses. ..
- MRI Progression Markers of Cognitive Decline in the ElderlyHenry Rusinek; Fiscal Year: 2010....
- CLINICAL CORRELATES OF LONGITUDINAL PET CHANGES IN ADMony de Leon; Fiscal Year: 2000..Early detection of AD will facilitate testing treatments under conditions of less brain damage. ..
- PREDICTORS OF COGNITIVE DECLINE IN NORMAL AGINGMony de Leon; Fiscal Year: 2002..Over 36 months, all subjects will receive 3 cognitive evaluations and 2 MRI scans. The results will improve our knowledge of the progression of brain changes underlying memory decline in aging. ..
- Biomarkers in Early Alzheimer's Disease (AD).Henry Rusinek; Fiscal Year: 2010....
